Mycoplasma genitalium membrane lipoprotein induces GAPDH malonylation in urethral epithelial cells to regulate cytokine response
Microbial Pathogenesis · 2024
DOI: 10.1016/j.micpath.2024.106872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2024. Verfasst von Xiaoliu Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital, Hengyang Medical College, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Epithelial Cells, Cytokines, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Membrane lipoproteins serve as primary pro-inflammatory virulence factors in Mycoplasma genitalium. Membrane lipoproteins primarily induce inflammatory responses by activating Toll-like Receptor 2 (TLR2); however, the role of the metabolic status of urethral epithelial cells in inflammatory response remains unclear. In this study, we found that treatment of uroepithelial cell lines with M. genitalium membrane lipoprotein induced metabolic reprogramming, characterized by increased aerobic glycolysis, decreased oxidative phosphorylation, and increased production of the metabolic intermediates acetyl-CoA and malonyl-CoA. The metabolic shift induced by membrane lipoproteins is reversible upon blocking MyD88 and TRAM. Malonyl-CoA induces malonylation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and malonylated GAPDH could dissociate from the 3' untranslated region of TNF-α and IFN-γ mRNA. This dissociation greatly reduces the inhibitory effect on the translation of TNF-α and IFN-γ mRNA, thus achieving fine-tuning control over cytokine secretion. These findings suggest that GAPDH malonylation following M. genitalium infection is an important inflammatory signal that plays a crucial role in urogenital inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital, Hengyang Medical College, University of South China, Hengyang, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital, Hengyang Medical College, University of South China, Hengyang, China.
- Institute of Pathogenic Biology, Hengyang Medical College, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, University of South China, Hengyang, China.
- Department of Clinical Laboratory, Shanghai Putuo People's Hospital, Tongji University, Shanghai, China.
- Department of Clinical Laboratory, The Second Affiliated Hospital, Hengyang Medical College, University of South China, Hengyang, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital, Hengyang Medical College, University of South China, Hengyang, China. Electronic address: helu@usc.edu.cn.
Förderung
- Natural Science Foundation of Hunan Province
Zitieren
APA
Wang, X., Hu, Y., Li, X., Huang, L., Yang, Y., Liu, C., Deng, Q., Yang, P., Li, Y., Zhou, Y., Xiao, L., Wu, H., & He, L. (2024). Mycoplasma genitalium membrane lipoprotein induces GAPDH malonylation in urethral epithelial cells to regulate cytokine response. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2024.106872
Vancouver
Wang X, Hu Y, Li X, Huang L, Yang Y, Liu C, et al. Mycoplasma genitalium membrane lipoprotein induces GAPDH malonylation in urethral epithelial cells to regulate cytokine response. Microbial Pathogenesis. 2024. doi:10.1016/j.micpath.2024.106872
BibTeX
@article{Wang2024,
author = {Wang, Xiaoliu and Hu, Yi and Li, Xinru and Huang, Liubin and Yang, Yan and Liu, Chang and Deng, Qing and Yang, Pei and Li, Yilin and Zhou, Yiwen and Xiao, Lihua and Wu, Haiying and He, Lu},
title = {Mycoplasma genitalium membrane lipoprotein induces GAPDH malonylation in urethral epithelial cells to regulate cytokine response},
journal = {Microbial Pathogenesis},
year = {2024},
doi = {10.1016/j.micpath.2024.106872}
}
EUVIMED